Document is current
Any future updates will be listed below
-
Authors
Bdeir, Najat
Lüddecke, Tatjana
Maaß, Henrike https://orcid.org/0000-0002-4654-5423
Schmelz, Stefan
Rand, Ulfert https://orcid.org/0000-0002-5946-4921
Jacobsen, Henning https://orcid.org/0000-0002-7831-1330
Metzdorf, Kristin
Kulkarni, Upasana
Cossmann, Anne
Stankov, Metodi V. https://orcid.org/0000-0003-3001-2478
Hoffmann, Markus https://orcid.org/0000-0003-4603-7696
Pöhlmann, Stefan https://orcid.org/0000-0001-6086-9136
Blankenfeldt, Wulf https://orcid.org/0000-0001-9886-9668
Dopfer-Jablonka, Alexandra https://orcid.org/0000-0001-7129-100X
Behrens, Georg M. N. https://orcid.org/0000-0003-3111-621X
Čičin-Šain, Luka https://orcid.org/0000-0003-3978-778X
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FOR2830)
- License Information
-
More Information
Article History
Received: 11 January 2024
Accepted: 2 January 2025
First Online: 18 January 2025
Competing interests
: L.C.-S. served as an advisor to Sanofi unrelated to this work. G.M.N.B. served as advisor for Moderna unrelated to this work, A.D.-J. served as an advisor for Pfizer unrelated to this work, S.P. and M.H. conducted contract research (testing of vaccinee plasma for neutralizing activity against SARS-CoV-2) for Valneva unrelated to this work. S.P. served as advisor for BioNTech, unrelated to this work. H.J. served as advisor on COVID neutralization assays for WHO and CEPI, unrelated to this work. The other authors declare no competing interests.
